北京和贵州地区50岁及以上女性宫颈癌筛查结果分析
回顾性分析2013年1月至2014年1月北京大学人民医院和贵州医科大学附属医院宫颈病变门诊≥50岁女性的筛查资料,以组织病理学为金标准,比较两地细胞学与HPV检测对CIN2+的筛查效力。两地≥50岁女性CIN2+占比较高,细胞学NILM和ASC-US比例及高危型HPV检测对CIN2+诊断灵敏度在两地间差异有统计学意义。
要点
- 北京组和贵州组阴道镜检出CIN2+患者中≥50岁女性分别占44.1%(82/186)和57.0%(98/172)。
- 北京组和贵州组宫颈癌患者中从未筛查者分别占50.0%(19/38)和73.2%(30/41)。
- 高危型HPV检测对CIN2+诊断灵敏度北京组95.2%(40/42) vs 贵州组73.6%(39/53),差异有统计学意义(P<0.05)。
核心结论
- 北京和贵州地区≥50岁女性CIN2+的发病率均处于较高水平。
- 北京和贵州地区宫颈细胞学和HPV检测对于CIN2+的检出存在差异。
研究设计与样本
- 回顾性分析2013年1月至2014年1月在北京大学人民医院和贵州医科大学附属医院妇产科宫颈病变门诊检查的≥50岁女性宫颈癌筛查资料。
- 以组织病理学为金标准,比较2个地区细胞学和高危型HPV检测对≥50岁女性宫颈癌的筛查效力。
主要发现
- 北京组和贵州组CIN2+患者中因有临床症状而就诊者分别占39.0%(32/82)和31.6%(31/98)。
- 北京组和贵州组CIN2+患者宫颈细胞学为NILM者分别占5.4%(4/74)和19.2%(10/52),差异有统计学意义(P=0.015)。
- 北京组和贵州组CIN2+患者宫颈细胞学为ASC-US者分别占10.2%(13/127)和24.6%(14/57),差异有统计学意义(P=0.010)。
- 北京组和贵州组CIN2+患者宫颈细胞学为LSIL者分别占14.9%(11/74)和37.5%(6/16),差异无统计学意义(P=0.080)。
- 北京组和贵州组CIN2+患者宫颈细胞学为ASC-H者分别占41.7%(5/12)和71.4%(20/28),差异无统计学意义(P=0.150);为HSIL者分别占78.9%(15/19)和86.4%(19/22),差异无统计学意义(P=0.830)。
关键数值与推荐
- 北京组和贵州组高危型HPV检测对CIN2+诊断的灵敏度分别为95.2%(40/42)和73.6%(39/53),差异有统计学意义(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the screening results of cervical cancer in elderly women in Beijing and Guizhou. To compare the screening effectiveness of cervical cancer in elderly women in different areas. Methods: A retrospective analysis was performed on the screening data of elderly women (≥50 years) who had examination at cervical lesion clinic in Peking University People's Hospital and Affiliated Hospital of Guizhou Medical University from January 2013 to January 2014, with histopathology as the gold standard, to compare screening effectiveness of cervical cytology or HPV detection for elderly women in cervical cancer screening in the two regions. Results: Among the patients with cervical intraepithelial neoplasia grade 2 and above (CIN2 + ) detected by colposcopy in Peking University People's Hospital and Affiliated Hospital of Guizhou Medical University, 44.1% (82/186) and 57.0% (98/172) were women aged 50 and older. In Beijing group 39.0% (32/82) of CIN2 + patients had clinical symptoms, which in Guizhou group was 31.6% (31/98). In Beijing group and Guizhou group, 50.0% (19/38) and 73.2% (30/41) patients with cervical cancer had never been screened, respectively. In Beijing group and Guizhou group, 5.4% (4/74) and 19.2% (10/52) of the patients with CIN2 + had cervical cytology negative for intraepithelial lesion or malignancy (NILM), respectively (P=0.015). The cervical cytology showed atypical squamous cells of undetermined significance (ASC-US) in 10.2% (13/127) and 24.6% (14/57), respectively, with significant difference (P=0.01). The cervical cytology showed low-grade squamous intraepithelial lesions (LSIL) in 14.9% (11/74) and 37.5% (6/16) with no significant difference (P=0.08). Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions (ASC-H) were 41.7% (5/12) and 71.4% (20/28) with no statistically significant difference (P=0.15). High-grade squamous intraepithelial lesions (HSIL) were 78.9% (15/19) and 86.4% (19/22) with no significant difference (P=0.83). In cases with HPV detection information, the sensitivity of CIN2+ diagnosis by high-risk HPV detection in Beijing group and Guizhou group was 95.2% (40/42) and 73.6% (39/53) that was statistically significant (P<0.05). Conclusions: In both Beijing and Guizhou, the incidence of CIN2+ in elderly women is at a relatively high level. There were differences in the detection of CIN2+ by cervical cytology or HPV detection in Beijing and Guizhou. 目的: 分析北京和贵州地区≥50岁女性宫颈癌的筛查结果,比较不同地区老年女性宫颈癌的筛查效力。 方法: 回顾性分析2013年1月至2014年1月分别在北京大学人民医院和贵州医科大学附属医院妇产科宫颈病变门诊进行检查的≥50岁女性受检者的宫颈癌筛查资料,以组织病理学为金标准,比较2个地区细胞学和人乳头状瘤病毒(HPV)检测对≥50岁女性宫颈癌的筛查效力。 结果: 在北京大学人民医院和贵州医科大学附属医院阴道镜门诊检出的宫颈上皮内瘤变2级及以上(CIN2+)患者中,≥50岁女性分别占44.1%(82/186)和57.0%(98/172)。北京组和贵州组CIN2+患者中,因有临床症状而就诊者分别占39.0%(32/82)和31.6%(31/98)。北京组和贵州组宫颈癌患者中,从未进行过筛查者分别为50.0%(19/38)和73.2%(30/41)。在北京组和贵州组CIN2+患者中,宫颈细胞学为无上皮内病变或恶性病变者分别占5.4%(4/74)和19.2%(10/52),差异有统计学意义(P=0.015);宫颈细胞学为不明确意义的非典型鳞状上皮细胞分别占10.2%(13/127)和24.6%(14/57),差异有统计学意义(P=0.010);宫颈细胞学为低度鳞状上皮内病变分别占14.9%(11/74)和37.5%(6/16),差异无统计学意义(P=0.080);宫颈细胞学为不除外高度病变的非典型鳞状上皮细胞分别占41.7%(5/12)和71.4(20/28),差异无统计学意义(P=0.150);宫颈细胞学为高度鳞状上皮内病变分别占78.9%(15/19)和86.4%(19/22),差异无统计学意义(P=0.830)。对有HPV检测结果的病例进行分析,北京组、贵州组高危型HPV检测对CIN2+诊断的灵敏度分别为95.2%(40/42)和73.6%(39/53),差异有统计学意义(P<0.05)。 结论: 无论在北京还是贵州地区,≥50岁女性CIN2+的发病率均处于较高水平。北京和贵州地区宫颈细胞学和HPV检测对于CIN2+的检出存在差异。.
引用
- Guo GZ, Zhao Y. [Analysis of cervical cancer screening results in women aged 50 and older in Beijing and Guizhou]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30605984. doi:10.3760/cma.j.issn.0253-3766.2018.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。